An international research firm focused on providing profit bolstering data driven solutions to the healthcare industryCEO Generated hundreds of millions of dollars in new sales and profit for a host of international clients by delivering to client companies, the necessary information and strategy to realign their sales and marketing teams for enhanced results.Saved eight tier one clients hundreds of millions of dollars by initiating a syndicated research study detailing quality and relationships between client's sales force and customers. This study provided proof of marketplace needs and acted as a catalyst for a revolutionary re-engineering of sales personnel teams effectively raising margin without sacrificing market share. As a result of a syndicated research study of the Type 2 Diabetes marketplace, found a huge opportunity for growth due to an ill-informed and high at-risk patient base. Clients were able to create key initiatives aligning sales and marketing functions while educating the consumer, which brought wellness to patients and millions of dollars to the bottom line. Advised a tier one client, of an alternative use for a time tested product and strategy for receiving FDA approval and exclusivity. Total marketplace potential was greatly expanded.

Overseeing staff in PA, Arizona, Canada, UK, France, Amsterdam. etc; market research, for Pharma companies.

worked with senior management at brand-name pharmaceutical companies to create unique marketing, market research, and competitive intelligence projects; managed professional level staff and directed all groups, who comprised the company; responded to client requests for speeches and presentations, pertaining to results of our studies

Worked with senior management at brand-name pharmaceutical companies to create both syndicated and proprietary/competitive research projects; responded to executive requests to deliver many speeches and presentations to their company executives; directed, coached, and supervised the executives within Scott-Levin, as well as their respective staff

An innovative market research firm servicing pharmaceutical executives and allied trade groups CEOA pioneer in the field of pharmaceutical research. Conceptualized, built and grew the company to become the industry standard. Spearheaded growth from 2-person start-up to 125 employees and $10 million in revenues in 9 years.Created business from scratch and with no external funding achieved first year profits in excess of $250,000.Went head to head against former employer who had monopolized market research audits for 50 years, garnering an 88% market share within 2 years of inception.Conducted a syndicated quantitative and qualitative study on direct-to-consumer advertising of prescription drugs, by directly lobbying with government regulators and congress. This resulted in the Food and Drug Administration lifting its ban.Leveraged company to such strong market share and financial positioning, three companies including IMS, Medco and PMSI negotiated for acquisition of Scott-Levin resulting in the profitable sale to PMSI. Identified industry needs and conceptualized solutions for major pharmaceutical clients. This included refocusing company sales initiatives to the needs of their client physicians, successfully adding hundreds of millions of dollars in new revenue.

A publicly traded clinical trials and contract sales provider acquiring PMSI/Scott-Levin in 1999

Strategically positioned Scott-Levin to fit within Informatics, a division of Quintiles. Led the integration and creation of an infrastructure of three combined entities with $250 million in sales, designing three client applications which are still being profitably marketed to tier one pharmaceutical companies.Quintiles (NASDAQ-QTRN) acquired PMSI for $197 million, $107 million of which was attributed to Scott-Levin.Professional Experience is continued on; Formed as a holding company by UK based Walsh International, an international pharmaceutical marketing conglomerate; Grew Scott-Levin business unit from $10 million to $30 million in revenue, leading an international business of over 250 employees, while achieving operating profits in excess of 25%.Created and launched the marketing concept for a CEO client, who had targeted a very small segment of the population suffering from incontinence. The concept of "overactive bladder" was created and marketed, exceeding initial product revenue estimates of $100 million, by several billion dollars. Provided specific business intelligence and strategic vision to "tier one" clients within the healthcare and pharmaceutical sectors, to take advantage of the new direct to consumer advertising regulations.

Vice President, Software Development, Operations, Production Control, Data ControlVice President, Online services and client training/support

Worked with all the marketing/market research executives and staff at all brand-name pharmaceutical companies, specifically on the most effective use if IMS' time-sharing system, which was accessed via a proprietary software language.

A leading provider of sales management and market research services to clients in the pharmaceutical and health care industries; Responsible for the marketing and growth of on-line data services. Marketed a full package of surveys to 20 clients in one year generating over $14 million in revenues and necessitating the creation of a new division of the firm.